FdaApplication
ANDA 206761
Identifiers
- fda_app_no: ANDA206761
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI IPSUM SRL |
| application_type | ANDA |
| approval_date | 2020-06-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | EQ 10GM BASE/VIAL | INJECTABLE;INJECTION |
1 product